<html lang="en-US">
<head>
    <meta charset="UTF-8">
    <script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-87917782-1', 'auto');
  ga('send', 'pageview');
</script>


    
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/css/bootstrap.min.css" integrity="sha384-1q8mTJOASx8j1Au+a5WDVnPi2lkFfwwEAa8hDDdjZlpLegxhjVME1fgjWPGmkzs7" crossorigin="anonymous">
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/js/bootstrap.min.js" integrity="sha384-0mSbJDEHialfmuBBQP6A4Qrprq5OVfW37PRR3j5ELqxss1yVqOtnepnHVP9aJ7xS" crossorigin="anonymous"></script>
<script>
$(document).ready(function(){
  $('[data-toggle="tooltip"]').tooltip();
});
</script>


<link rel="stylesheet" href="layout/styling/base.css">
<title>SCALLOP - genetic regulation of the proteome</title>
<meta name="description" content="System to serve protein quantiative trait loci data (pQTL).">
<meta name="keywords" content="genetic, genetic disease, mendelian randomization">	
</head>
<body>

   
 <nav class="navbar navbar-default  navbar-fixed-top">
  <div class="container">
    <!-- Brand and toggle get grouped for better mobile display -->
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="#">SCALLOP</a>
    </div>

    <!-- Collect the nav links, forms, and other content for toggling -->
    <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
     
     
      <ul class="nav navbar-nav navbar-right">
           <li><a href="http://www.scallop-consortium.com/">Home</a></li>
            <li><a href="/terms_of_use/">Terms-of-use</a></li>
        <li class="dropdown">
          <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Modules <span class="caret"></span></a>
          <ul class="dropdown-menu">
          <li><a href="/scallop_protein_centric/">SCALLOP: Protein-centric browser</a></li>
          <li><a href="/scallop_dna_region/">SCALLOP: Genome-region browser</a></li>
          <li><a href="/scallop_pathways/">SCALLOP: Trans-pQTL pathways</a></li>
          <li><a href="/scallop_downloads/">SCALLOP: Data downloads</a></li>

          <li><a href="/improve_protein_centric/">IMPROVE: Protein-centric browser <i>(legacy)</i></a></li>
          <li><a href="/improve_dna_region/">IMPROVE: Genome-region browser <i>(legacy)</i></a></li>
          <li><a href="/improve_downloads/">IMPROVE: Data downloads <i>(legacy)</i></a></li>
          </ul>
        </li>
      </ul>
    </div><!-- /.navbar-collapse -->
  </div><!-- /.container-fluid -->
</nav>
 <div class="title-block">
  <div class="container">
    <h1>SCALLOP - genetic regulation of the proteome</h1>
  </div>
</div>
 

 <div class='container' align='center' style="font-size:16px">

  <!--[if lt IE 11]>
<b>Your browser is Internet explorer. This browser cannot be used. Please use either Chrome or Firefox.</b><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br />
<![endif]-->

<img src=../www/composite-banner-scallop.png alt='' style="width:90%">
<h1>SCALLOP genetics of the proteome</h1>
<br>
<p align="left" style="width:80%">The SCALLOP consortium (Systematic and Combined AnaLysis of Olink Proteins) is a collaborative framework for discovery and follow-up of genetic associations with proteins on the Olink Proteomics platform. To date, 35 PIs from 28 research institutions have joined the effort, which now comprises summary level data for more than 70,000 patients and controls from 45 cohort studies. SCALLOP welcomes new members.</p>
<br>  
<p align="center">For more information please contact <u><a href='mailto:Anders.Malarstig@ki.se?subject=Scallop%20inquiry%20from%20scallopconsortium.com'><font color="0E90A4"> Anders Mälarstig</a></u><font color="000000"> (SCALLOP project chair).</p>
<p align="center">For the latest news about SCALLOP view this <u><a href='https://www.olink.com/scallop/scallop-news/' target="_blank"><font color="0E90A4">NEWS page,</a></u></p>
<p align="center">or read more in our <u><a href=../www/Scallop_Flyer_v1.1.pdf target="_blank"><font color="0E90A4">flyer</a></u>.</p>
<br><br>
<h2>Introduction from Anders Mälarstig</h2>
<br>
<iframe width='85%' height='524' src='https://www.youtube.com/embed/GEbRaaZtizg' frameborder='0' allow='accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture' allowfullscreen></iframe>
<br><br><br>
<p><img src='../www/scallop_logo.png' alt='' width='200' height='121'></p>
<br>
<h2>Current work</h2>
<br>
<p align="left" style="width:80%">Each SCALLOP member works on human study collections from the general population, clinical trials or patients with certain diseases such as coronary artery disease, rheumatoid arthritis, bipolar disease, heart failure, dementias or metabolic syndrome.</p>
<p align="left" style="width:80%">The aim of the SCALLOP consortium is to identify novel molecular connections and protein biomarkers that are causal in diseases.</p>
<p align="left" style="width:80%">This work starts with identification of so called protein quantitative trait loci, pQTLs, which are robust connections between a gene variant and the levels of a protein.</p>
<p align="left" style="width:80%">There are two types of pQTLs:</p>
<ul><font color="000000">
<li align="left" style="width:80%"><font color="000000">cis-pQTLs are variants that are proximal to the gene encoding the protein under study whereas trans-pQTLs are distal regulation of proteins via an often unknown path.</li>
<li align="left" style="width:80%"><font color="000000">Trans-pQTLs can provide unique insights of molecular connections in human biology.</li>
</ul>
<p align="left" style="width:80%">Cis-pQTLs are strong instruments for determining if a protein biomarker for disease is causing disease or elevated or suppressed as a consequence of it. The SCALLOP consortium is currently underway with mapping novel pQTLs for several 100s of proteins in unprecedented sample sizes, something which will yield much deeper insights into the trans-regulation of plasma proteins than what has been possible to date.</p>
<br><br><br>
<h2>Identify causal protein biomarkers</h2>
<br><br>
<p><img src='../www/scallop-infographic.png' width='80%'></p>
<br><br><br>
<h2>Operations</h2>
<br>
<p align="left" style="width:80%">To be a member of the SCALLOP consortium you have to be the PI of a study collection with Olink proteomics and genome-wide genotyping data. We also expect members to sign up to the Consortium Agreement, which manages conduct and authorships. <u><a href='../www/SCALLOP_consortium_agreement_March_2019.pdf' target='_blank' rel='noopener'><font color="0E90A4">Download the&nbsp;Consortium Agreement here</a></u>.</p>
<p align="left" style="width:80%">The leadership for subprojects within the SCALLOP consortium rotates and members can take new ideas and suggestions for additional subprojects to the monthly steering committee meetings.</p>
<p align="left" style="width:80%">SCALLOP uses a dedicated server for sharing of data. The server is set up under the Danish node of the TRYGGVE server structure. TRYGGVE allows sharing of sensitive data thanks to 2-step authorization procedures and high data security. Thanks to this structure SCALLOP is set up to move to individual-level data should the consortium wish to do so.</p>
<br><br><br>
<h2>Repository browser</h2>
<br>
<table style="width:80%">
<tbody>
<tr bgcolor='#077183'>
<td width='300' style="padding:10px"><span style='color: #077183;'><strong><span style='color: #ffffff;'>Acronym</span></strong></span></td>
<td width='300'><span style='color: #ffffff;'><strong>Design</strong></span></td>
<td width='200' align="center"><span style='color: #ffffff;'><strong>Sample size</strong></span></td>
<td width='200' align="center"><span style='color: #ffffff;'><strong>Olink panels</strong></span></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.sciencedirect.com/science/article/abs/pii/S0002870309009454' target="_blank"><font color="0E90A4">Aristotle</a></td>
<td>Atrial fibrillation</td>
<td align="center">1500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>		

<tr>
<td style="padding:10px"><a href='http://www.ki.se/en/meds/team-per-eriksson' target="_blank"><font color="0E90A4">ASAP</a></td>		
<td>Aortic valve surgery</td>		
<td align="center">573</td>
<td align="center"><a data-toggle="tooltip" title="CVD-III, MET, CM, IR, DEV" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://ki.se/en/imm/bamse-project' target="_blank"><font color="0E90A4">BAMSE</a></td>		
<td>Childhood asthma</td>		
<td align="center">2000</td>
<td align="center"><a data-toggle="tooltip" title="INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://bialystok.plus/en/english/' target="_blank"><font color="0E90A4">Bialystok PLUS</a></td>		
<td>Population based, CVD/CHD</td>		
<td align="center">899</td>
<td align="center"><a data-toggle="tooltip" title="CVD-III, INF, MET, CM, IR" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://biofinder.se/' target="_blank"><font color="0E90A4">BioFinder</a></td>
<td>Dementia</td>
<td align="center">1550</td>
<td align="center"><a data-toggle="tooltip" title="CVD-III, INF, NEU, NEX" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">4</a></td>
</tr>
    
<tr>
<td style="padding:10px"><a href='https://www.cardia.dopm.uab.edu/' target="_blank"><font color="0E90A4">CARDIA</a></td>
<td>Prospective, young adults</td>
<td align="center">2000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">2</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://snd.gu.se/en/catalogue/study/ext0015' target="_blank"><font color="0E90A4">COSM-C</a></td>
<td>Population based</td>
<td align="center">4500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, MET" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1388-z' target="_blank"><font color="0E90A4">Dan-NICAD</a></td>
<td>Stable coronary artery disease</td>
<td align="center">1650</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>    

<tr>
<td style="padding:10px"><a href='https://clinicaltrials.gov/ct2/show/NCT03814915' target="_blank"><font color="0E90A4">DIRECT</a></td>
<td>Diabetes</td>
<td align="center">3000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, MET, CM" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://pubmed.ncbi.nlm.nih.gov/23435790/' target="_blank"><font color="0E90A4">EpiHealth</a></td>
<td>Prospective observational</td>
<td align="center">2500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, MET" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.geenivaramu.ee/en/access-biobank' target="_blank"><font color="0E90A4">Estonian Biobank</a></td>
<td>Population based</td>
<td align="center">500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, ONC-I" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">4</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.phpc.cam.ac.uk/pcu/research/research-projects-list/other-projects/fenland/' target="_blank"><font color="0E90A4">FENLAND</a></td>
<td>Population based</td>
<td align="center">500</td>
<td align="center"><a data-toggle="tooltip" title="All available" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">15</a></td>
</tr>
    
<tr>
<td style="padding:10px"><a href='http://https://flemengho.eu/' target="_blank"><font color="0E90A4">FLEMENGHO</a></td>
<td>Population based</td>
<td align="center">3500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://framinghamheartstudy.org/fhs-about/' target="_blank"><font color="0E90A4">Framingham</a></td>
<td>Population based</td>
<td align="center">520</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, CM, OD" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.helmholtz-muenchen.de/index.php?id=53481' target="_blank"><font color="0E90A4">HELIC MANOLIS</a></td>
<td>Population based</td>
<td align="center">1356</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, MET, NEU, NEX" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242463/' target="_blank"><font color="0E90A4">HELIC POMAK</a></td>
<td>Population based</td>
<td align="center">1537</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, DVD-III, MET, NEU, NEX" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>
    
<tr>
<td style="padding:10px"><a href='https://iammyhealth.eu/en/i-am-frontier' target="_blank"><font color="0E90A4">I AM Frontier</a></td>
<td>Deep phenotyping, Longitudinal</td>
<td align="center">240</td>
<td align="center"><a data-toggle="tooltip" title="All available" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">15</a></td>
</tr>
    
<tr>
<td style="padding:10px"><a href='https://ki.se/en/meds/team-bruna-gigante' target="_blank"><font color="0E90A4">IMPROVE</a></td>
<td>Prospective, metabolic syndrome</td>
<td align="center">3403</td>
<td align="center"><a data-toggle="tooltip" title="CVD-I" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.intervalstudy.org.uk/' target="_blank"><font color="0E90A4">INTERVAL</a></td>
<td>Blood donors</td>
<td align="center">5000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, NEU" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">4</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.ckbiobank.org/' target="_blank"><font color="0E90A4">Kadoorie biobank</a></td>
<td>Pancreatic cancer</td>
<td align="center">1400</td>
<td align="center"><a data-toggle="tooltip" title="IO" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://karmastudy.org/' target="_blank"><font color="0E90A4">KARMA</a></td>
<td>Incident breast cancer</td>
<td align="center">1820</td>
<td align="center"><a data-toggle="tooltip" title="INF, CM" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">2</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.helmholtz-muenchen.de/epi/research/research-groups/diabetes-epidemiology/projects/the-kora-s4f4ff4-longitudinal-study-on-prediabetes/index.html' target="_blank"><font color="0E90A4">KORA F4</a></td>
<td>Population based</td>
<td align="center">1050</td>
<td align="center"><a data-toggle="tooltip" title="INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://mrc.ukri.org/research/facilities-and-resources-for-researchers/cohort-directory/lothian-birth-cohort-1936-lbc1936/' target="_blank"><font color="0E90A4">LBC1936</a></td>
<td>Population aged 72</td>
<td align="center">750</td>
<td align="center"><a data-toggle="tooltip" title="NEU" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.lifelines.nl/researcher/data-and-biobank/additional-study/additional-data-samples-2' target="_blank"><font color="0E90A4">LifeLines Deep</a></td>
<td>Population based</td>
<td align="center">1200</td>
<td align="center"><a data-toggle="tooltip" title="CVD-III" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.pfizer.com/' target="_blank"><font color="0E90A4">Pfizer/ MadCam_ph2</a></td>
<td>Inflammatory bowel disease</td>
<td align="center">200</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://snd.gu.se/en/catalogue/study/ext0013' target="_blank"><font color="0E90A4">MPP-RES</a></td>
<td>Heart failure</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-III" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.ncbi.nlm.nih.gov/pubmed/20568910' target="_blank"><font color="0E90A4">NSPHS</a></td>
<td>Population isolate</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-I, CVD-II, CVD-III, INF, NUE, ONC-I" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">6</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.ed.ac.uk/viking/about-us/our-studies' target="_blank"><font color="0E90A4">ORCADES</a></td>
<td>Population isolate</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="All available" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">15</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.medsci.uu.se/pivus/' target="_blank"><font color="0E90A4">PIVUS</a></td>
<td>Prospective observational</td>
<td align="center">933</td>
<td align="center"><a data-toggle="tooltip" title="CVD-I"" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://clinicaltrials.gov/ct2/show/NCT04657367' target="_blank"><font color="0E90A4">POLRED</a></td>
<td>Population-based, diabetes</td>
<td align="center">1500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-III, INF, CM, IR, MET" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">5</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.narcis.nl/research/RecordID/OND1365896/Language/en' target="_blank"><font color="0E90A4">PRIDE</a></td>
<td>Dementia</td>
<td align="center">1500</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, NEU, NEX, MET, CM, IR, OD, ONC-I, ONC-II, CR, DEV, IO" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">14</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.well.ox.ac.uk/research/research-groups/watkins-group-inherited-heart-muscle-disease-group-1/procardis' target="_blank"><font color="0E90A4">PROCARDIS</a></td>
<td>Coronary artery disease</td>
<td align="center">900</td>
<td align="center"><a data-toggle="tooltip" title="INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://pubmed.ncbi.nlm.nih.gov/19540385/' target="_blank"><font color="0E90A4">PURE</a></td>
<td>Epidemiological cohort</td>
<td align="center">8000</td>
<td align="center"><a data-toggle="tooltip" title="All available" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">15</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://academic.oup.com/jcem/article/99/3/E479/2537128' target="_blank"><font color="0E90A4">Qmdiab</a></td>
<td>Diabetes</td>
<td align="center">320</td>
<td align="center"><a data-toggle="tooltip" title="MET, CM" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">2</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://pubmed.ncbi.nlm.nih.gov/27532898/' target="_blank"><font color="0E90A4">RECOMBINE</a></td>
<td>Rheumatoid arthritis</td>
<td align="center">800</td>
<td align="center"><a data-toggle="tooltip" title="INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.egir.org/egirrisc/index.html' target="_blank"><font color="0E90A4">RISC</a></td>
<td>Prospective observational</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, MET, CM, IR, OD, ONC-II, DEV" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">9</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662692/' target="_blank"><font color="0E90A4">Rotterdam</a></td>
<td>Population based</td>
<td align="center">250</td>
<td align="center"><a data-toggle="tooltip" title="NEU" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250962/' target="_blank"><font color="0E90A4">Rotterdam Study-III cohort</a></td>
<td>Population based</td>
<td align="center">3500</td>
<td align="center"><a data-toggle="tooltip" title="INF, CM" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">2</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://clinicaltrials.gov/ct2/show/NCT01127698' target="_blank"><font color="0E90A4">SMCC/ SIMPLER</a></td>
<td>Population based, women</td>
<td align="center">5000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, MET" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.nejm.org/doi/full/10.1056/NEJMoa1315878#t=article%C2%A0' target="_blank"><font color="0E90A4">STABILITY</a></td>
<td>Acute coronary syndrome</td>
<td align="center">3000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-I, INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">2</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://ki.se/meb/swebic' target="_blank"><font color="0E90A4">STANLEY</a></td>
<td>Bipolar disorder, depression</td>
<td align="center">681</td>
<td align="center"><a data-toggle="tooltip" title="CVD-I, INF, NEU, ONC-I" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">4</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://swhs-smhs.app.vumc.org/' target="_blank"><font color="0E90A4">SWHS/ SMHS/ SCCS</a></td>
<td>Population based</td>
<td align="center">300</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, NEU, NEX, MET, CM, IR, OD, ONC-I, ONC-II, CR, DEV, IO" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">14</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.pubcare.uu.se/ulsam/' target="_blank"><font color="0E90A4">ULSAM</a></td>
<td>Prospective observational</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, MET, CM, IR, OD, ONC-II, DEV" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">9</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='http://www.ed.ac.uk/mrc-human-genetics-unit/research/qtl-group/' target="_blank"><font color="0E90A4">VIS</a></td>
<td>Population isolate</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">3</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://www.whi.org/page/about-whi' target="_blank"><font color="0E90A4">WHI</a></td>
<td>Clinical trial, mixed population, women</td>
<td align="center">1400</td>
<td align="center"><a data-toggle="tooltip" title="CVD-II, CVD-III, INF, NEU, CM, ONC-I" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">6</a></td>
</tr>

<tr>
<td style="padding:10px"><a href='https://1000ibd.org/menu/main/background' target="_blank"><font color="0E90A4">1000IBD</a></td>
<td>Crohn’s disease and ulcerative colitis</td>
<td align="center">1000</td>
<td align="center"><a data-toggle="tooltip" title="INF" href='https://www.olink.com/products/' target="_blank"><font color="0E90A4">1</a></td>
</tr>

</tbody>
</table>
<br><br>
<hr>
<br>
<h2>pQTL publications and data from SCALLOP members</h2>
<br>
<p align="left" style="width:80%">Bourgonje, A.R., Hu, S., Spekhorst, L.M., Zhernakova, D.V., Vich Vila, A., Li, Y., ... & Weersma, R.K. (2022).<strong>&nbsp;The effect of phenotype and genotype on the plasma proteome in patients with Inflammatory Bowel Disease.</strong>&nbsp; Journal of Crohn's and Colitis, 16(3), 414-429.<a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919819/' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Macdonald-Dunlop, E., Klarić, L., Folkersen, L., Timmers, P. R., Gustafsson, S., Zhao, J. H., ... & Wilson, J. F. (2021).<strong>&nbsp;Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and disease.</strong>&nbsp;medRxiv 2021.08.03.21261494.<a href=' https://www.medrxiv.org/content/10.1101/2021.08.03.21261494v1.full' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Lind, L., Gigante, B., Borné, Y., Feldreich, T., Leppert, J., Hedberg, P., ... & Mälarstig, A. (2021).<strong>&nbsp;Plasma protein profile of carotid artery atherosclerosis and atherosclerotic outcomes: meta-analyses and mendelian randomization analyses.</strong>&nbsp;Arteriosclerosis, Thrombosis, and Vascular Biology, 41(5), 1777-1788.<a href='https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.120.315597' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%"> Smith-Byrne, K., Chen, Y., Kachuri, L., Kapoor, P. M., Guida, F., Zahed, H., ... & Malarstig, A. (2021).<strong>&nbsp;IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor Expression.</strong>&nbsp;medRxiv 2021.03.26.21254400.<a href='https://www.medrxiv.org/content/10.1101/2021.03.26.21254400v1.full' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Klaric, L., Gisby, J. S., Papadaki, A., Muckian, M. D., Macdonald-Dunlop, E., Zhao, J. H., ... & Peters, J. E. (2021).<strong>&nbsp;Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19.</strong>&nbsp;medRxiv 2021.04.01.21254789.<a href='https://www.medrxiv.org/content/10.1101/2020.11.05.20223289v2' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Gisby, J., Clarke, C. L., Medjeral-Thomas, N., Malik, T. H., Papadaki, A., Mortimer, P. M., ... & Peters, J. E. (2020).<strong>&nbsp;Longitudinal proteomic profiling of high-risk patients with COVID-19 reveals markers of severity and predictors of fatal disease.</strong>&nbsp;medRxiv 2020.11.05.20223289.<a href=' https://www.medrxiv.org/content/10.1101/2020.11.05.20223289v1' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Pietzner, M., Wheeler, E., Carrasco-Zanini, J., Raffler, J., Kerrison, N. D., Oerton, E., ... & Langenberg, C. (2020).<strong>&nbsp;Genetic architecture of host proteins involved in SARS-CoV-2 infection.</strong>&nbsp;Nature communications, 11(1), 1-14.<a href=' https://www.nature.com/articles/s41467-020-19996-z' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Folkersen, L., Gustafsson, S., Wang, Q., Hansen, D. H., Hedman, Å. K., Schork, A., ... & Mälarstig, A. (2020).<strong>&nbsp;Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.</strong>&nbsp;Nature metabolism, 2(10), 1135-1148.<a href='https://www.nature.com/articles/s42255-020-00287-2' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a><font color="000000"> | Read more about the<strong>&nbsp;SCALLOP pQTL CVD I study</strong>&nbsp;on:<a href='https://www.olink.com/news/scallop-nature-metabolism/' target="_blank"><font color="0E90A4"> <u>SCALLOP news post</u></a><font color="000000"> and <a href='https://news.ki.se/new-major-proteogenomic-study-on-circulating-proteins-gives-new-insights-for-translational-studies' target="_blank"><font color="0E90A4"><u>KI news</u>.</a></p>
<br>
<p align="left" style="width:80%">Suhre, K., McCarthy, M. I., & Schwenk, J. M. (2020).<strong>&nbsp; Genetics meets proteomics: perspectives for large population-based studies.</strong>&nbsp;Nature Reviews Genetics, 1-19.<a href='https://pubmed.ncbi.nlm.nih.gov/32860016/' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Bretherick, A. D., Canela-Xandri, O., Joshi, P. K., Clark, D. W., Rawlik, K., Boutin, T. S., ... & Haley, C. (2020).<strong>&nbsp;Linking protein to phenotype with Mendelian Randomization detects 38 proteins with causal roles in human diseases and traits.</strong>&nbsp;PLoS genetics, 16(7), e1008785.<a href='https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1008785'  target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>
<p align="left" style="width:80%">Folkersen, L., Gustafsson, S., Wang, Q., Hansen, D. H., Hedman, A. K., Schork, A., ... & Malarstig, A. (2020).<strong>&nbsp;Genomic evaluation of circulating proteins for drug target characterisation and precision medicine.</strong>&nbsp;BioRxiv 2020.04.03.023804.<a href='https://www.biorxiv.org/content/10.1101/2020.04.03.023804v1.full.pdf' target="_blank"><font color="0E90A4"> <u>Article link</u></a><font color="000000"> | Read about the author’s perspective on the<strong>&nbsp;SCALLOP pQTL CVD I study</strong>&nbsp;on this<a href='https://www.olink.com/application/view-from-the-inside-scallop-pqtl-cvd-i-study/' target="_blank"><font color="0E90A4"> <u> SCALLOP news post</u></a>.</p>
<br>
<p align="left" style="width:80%">Folkersen, L., Fauman, E., Sabater-Lleal, M., Strawbridge, R. J., Frånberg, M., Sennblad, B., ... & Mälarstig, A. (2017).<strong>&nbsp;Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.</strong>&nbsp;PLoS genetics, 13(4), e1006706.<a href='https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1006706#sec002' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p>
<br>    
<p align="left" style="width:80%">Enroth, S., Johansson, Å., Enroth, S. B., & Gyllensten, U. (2014).<strong>&nbsp;Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs.</strong>&nbsp;Nature communications, 5(1), 1-11.<a href='https://pubmed.ncbi.nlm.nih.gov/25147954/' target="_blank"><font color="0E90A4"> <u>Αrticle link</u></a></p><br>
<hr>
<p>&nbsp;</p>


</div>


</div>

</body>
</html>




